Select a community
HIV
Find out more about the PatientsLikeMe
HIV Community
Home > Community Treatment Reports > Simvastatin Treatment Report
What is Simvastatin?

Simvastatin is an antilipid agent used with diet therapy to reduce risk for coronary heart disease, stroke and trans ischemic attacks (mini strokes); used to reduce total cholesterol, LDL-C and triglycerides and increase HDL-C; and for treatment of familial hypercholesterolemia (high cholesterol). Read more...Click to read more below

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken
# of patients Efficacy
Major
Moderate
Slight
None
Can’t tell 		# of patients evaluated by
High Cholesterol (Hypercholesterolemia) 5 0
Other 4 2
General health 3 0
due to hiv medication 1 0

See all 11 patients currently taking Simvastatin

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
0 0%
None
2 100%

Dosages

  5 mg daily 10 mg daily 20 mg daily 40 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 6 Number of Patients: 6  

Stop Reasons

Why Patients Stopped Taking Simvastatin (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice
1 33% Doctor's advice: 33%
Other
1 33% Other: 33%

See all 2 patients who’ve stopped taking Simvastatin

Duration See details about how long patients take this treatment ▼

Currently Taking Simvastatin

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Stopped Taking Simvastatin

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
2 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
2 100%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
1 50%

See more information, including instructions, precautions, side effects, and interactions.

Report created on March 22, 2010.